The FDA approved Bizengri (zenocutuzumab-zbco) for advanced unresectable or metastatic NRG1+ NSCLC or pancreatic adenocarcinoma.

Among generally healthy children and teenagers, NO2 exposure was linked to lower lung function and higher fractional exhaled nitric oxide.

Mild to moderate COPD with vs without emphysema is associated with significantly worse HRQOL, but similar lung function decline.

Each additional socioeconomic barrier a cancer survivor experienced was associated with a 40% reduction in the odds of vaccine uptake. Socioeconomic barriers reduce the odds of COVID-19 vaccination ...

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), as a single agent, for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has ...